How can people living with PD, their care partners and health teams maximize medications to ease symptoms and improve everyday life? Find tips by joining a one-hour online seminar led by PDF and Connie Marras, M.D., Ph.D., of Toronto Western Hospital, Canada.
- Review the classes of medication for Parkinson’s disease.
- Learn about what effects (good and bad) can be expected from PD medications.
- Understand ways (e.g., adjusting timing) to maximize the effectiveness of PD medications and minimize side effects.
In her clinical practice, Dr. Marras cares primarily for people living with Parkinson's disease. An active investigator, she focuses her research on understanding certain aspects of Parkinson’s disease, such as its epidemiology, the clinical expression of its genetic forms, environmental causes, etiology, disease prognosis and evaluation of clinical assessment tools. In fact, earlier in her career, in 2005, Dr. Marras received funding through the PDF-Parkinson Study Group Mentored Clinical Research Award, to lay the groundwork for a large observational study investigating the gene LRRK2 and Parkinson’s disease.
Dr. Marras serves as associate editor for the journal Movement Disorders and serves as vice-chair of the research ethics board of the University Health Network in Toronto.
Dr. Marras completed her Ph.D. in epidemiology at the University of Toronto, where she also supplemented her medical degree with specialized training in neurology and movement disorders. She received further training in epidemiologic research methods at the Parkinson’s Institute in Sunnyvale, CA.